@RBR been watching MYX for a while, and have traded it in the past.
Looking purely at historics, only in 2023 has it traded too far below this level. Ill either make some cash, or hold it until I do. There is an element of risk to all investments, and this is a calculated buy based on a few different factors.
At the price, its looking attractive. The fundamentals stack up as a value proposition given the health and future well being of all the economic reports. Debt to equity ratio is 7%. EPS growth rate is 114%. Pharma as an industry is growing, not shrinking.
Everyone looks at a company and buys based on a few things, but the overall economic landscape is just one more factor to warrant buying and like Buffet says, get greedy when others are fearful.
(20min delay)